How Many Subjects With Major Depressive Disorder Meet Eligibility Requirements of an Antidepressant Efficacy Trial?
J Clin Psychiatry 2003;64(9):1091-1093
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Objective: To evaluate the generalizability of
the results of antidepressant efficacy trials by determining how
many subjects with DSM-IV major depressive disorder who apply for
entry into such trials are ultimately enrolled.
Method: The screening results of 378 subjects
who inquired about participating in 1 of 2 separate
antidepressant efficacy trials performed at Rhode Island Hospital
between 1997 and 2002 were reviewed. The number of subjects who
enrolled, as well as the reasons for exclusion of those who did
not meet eligibility requirements, were determined.
Results: Of the 378 inquiries, 186 subjects
expressed interest and received a current major depressive
disorder diagnosis. From this sample, 27 (14.5%) were ultimately
enrolled in 1 of the 2 antidepressant trials. The most common
reasons for exclusion were bipolar disorder (17.2%), drug or
alcohol abuse (15.6%), mild depression (14.0%), medical
contraindication (12.9%), and the use of prohibited psychotropic
Conclusion: The majority of subjects with major
depressive disorder who apply to participate in an antidepressant
efficacy trial do not meet eligibility requirements. When
prescribing antidepressants, clinicians should bear in mind that
the results of these trials may only be directly applicable to a
small subset of patients treated in clinical practice.